Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
Herrero-Morant A, Álvarez-Reguera C, Martín-Varillas JL, Calvo-Río V, Casado A, Prieto-Peña D, Atienza-Mateo B, Maiz-Alonso O, Blanco A, Vicente E, Rúa-Figueroa Í, Cáceres-Martin L, García-Serrano JL, Callejas-Rubio JL, Ortego-Centeno N, Narváez J, Romero-Yuste S, Sánchez J, Estrada P, Demetrio-Pablo R, Martínez-López D, Castañeda S, Hernández JL, González-Gay MÁ, Blanco R. Herrero-Morant A, et al. J Clin Med. 2020 Aug 11;9(8):2608. doi: 10.3390/jcm9082608. J Clin Med. 2020. PMID: 32796717 Free PMC article.
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.
Herrero-Morant A, Martín-Varillas JL, Castañeda S, Maíz O, Sánchez J, Ortego N, Raya E, Prior-Español Á, Moriano C, Melero-González RB, Graña-Gil J, Urruticoechea-Arana A, Ramos-Calvo Á, Loredo-Martínez M, Salgado-Pérez E, Sivera F, Torre I, Narváez J, Andreu JL, Martínez-González O, Torre RG, Fernández-Aguado S, Romero-Yuste S, González-Mazón Í, Álvarez-Reguera C, Hernández JL, González-Gay MÁ, Blanco R; Neurobehçet Spanish Collaborative Group. Herrero-Morant A, et al. Rheumatology (Oxford). 2022 Nov 2;61(11):4427-4436. doi: 10.1093/rheumatology/keac097. Rheumatology (Oxford). 2022. PMID: 35166821 Review.
Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Martín-Varillas JL, González-López E, Gutiérrez-Larrañaga M, San Segundo D, Demetrio-Pablo R, Ocejo-Vinyals G, González-Gay MA, Blanco R. Álvarez-Reguera C, et al. Among authors: herrero morant a. Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221093211. doi: 10.1177/1759720X221093211. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35510170 Free PMC article.
Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review.
Martínez-López D, Ferraz-Amaro I, Prieto-Peña D, Sánchez-Bilbao L, Herrero-Morant A, Álvarez-Reguera C, Benavides-Villanueva F, Corrales-Selaya C, Trigueros-Vázquez M, González-Gay MÁ, Blanco R. Martínez-López D, et al. Among authors: herrero morant a. Front Med (Lausanne). 2022 Dec 12;9:1056374. doi: 10.3389/fmed.2022.1056374. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36579150 Free PMC article.
Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review.
De Vicente Delmás A, Sanchez-Bilbao L, Calvo-Río V, Martínez-López D, Herrero-Morant A, Galíndez-Agirregoikoa E, Gonzalez-Mazon I, Barroso-García N, Palmou-Fontana N, Gonzalez-Gay MA, Hernández JL, Blanco R. De Vicente Delmás A, et al. Among authors: herrero morant a. RMD Open. 2023 Jan;9(1):e002781. doi: 10.1136/rmdopen-2022-002781. RMD Open. 2023. PMID: 36635002 Free PMC article. Review.
Epidemiology and clinical domains of Behçet's disease in the Cantabria region, Northern Spain.
Suárez-Amorín G, Demetrio-Pablo R, Fernández-Ramón R, Herrero-Morant A, Álvarez-Reguera C, Sánchez-Bilbao L, Martínez-López D, Martín-Varillas JL, Castañeda S, González-Gay MA, Blanco R. Suárez-Amorín G, et al. Among authors: herrero morant a. Clin Exp Rheumatol. 2023 Oct;41(10):1991-1997. doi: 10.55563/clinexprheumatol/z32rhm. Epub 2023 Apr 21. Clin Exp Rheumatol. 2023. PMID: 37083163 Free article.
Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitors.
Álvarez-Reguera C, Prieto-Peña D, Herrero-Morant A, Sánchez-Bilbao L, Batlle-López A, Fernández-Luis S, Paz-Gandiaga N, Blanco R. Álvarez-Reguera C, et al. Among authors: herrero morant a. Eur J Intern Med. 2024 May;123:102-106. doi: 10.1016/j.ejim.2023.11.019. Epub 2023 Dec 2. Eur J Intern Med. 2024. PMID: 38044168